Advertisement

Ads Placeholder
Loading...

Ab&B Bio Tech Co Ltd.

2627.HK•HKSE
Healthcare
Drug Manufacturers - Specialty & Generic
HK$29.32
HK$-0.30(-1.01%)
Hong Kong Market opens in 10h 27m

Ab&B Bio Tech Co Ltd. (2627.HK) Stock Overview

Explore Ab&B Bio Tech Co Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap10.6B
P/E Ratio-83.33
EPS (TTM)$-0.65
ROE-1.43%
Fundamental Analysis

AI Price Forecasts

1 Month$33.43
3 Months$56.64
1 Year Target$48.72

2627.HK Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Ab&B Bio Tech Co Ltd. (2627.HK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 30.40, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $48.72.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -83.33 and a market capitalization of 10.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.01%
5-Day Change
-6.15%
1-Month Change
-44.05%
3-Month Change
-27.14%
6-Month Change
-38.76%
Year-to-Date (YTD) Change
-27.14%
1-Year Change
-11.90%
3-Year Change
-11.90%
5-Year Change
-11.90%
All-Time (Max) Change
-11.90%

Contact Information

https://www.abbbio.com
86 52 3868 19889
No. 32 Xinglin Road, Taizhou, NaN, 225300

Company Facts

IPO DateAug 11, 2025
CountryCN
Actively Trading

Frequently Asked Questions